Improving Hypertension Medication Adherence for Older Adults
Не применимо
Завершено
NCT05610059
| Заболевание | Aging, Medication Adherence, Hypertension |
|---|
| Фаза | Не применимо |
|---|
| Спонсор | University of Arizona |
|---|
| Статус | Завершено |
|---|
| Участники | 200 участн. |
|---|
| Вмешательство | Blood Pressure Technology System M, Blood Pressure Technology System E |
|---|
| Дата начала | 2.11.2022 |
|---|
| Дата завершения | 14.03.2025 |
|---|
| Публикация результатов | 31.07.2026 |
|---|
Кратко
This randomized controlled trial will assess the efficacy and scalability of a blood pressure technology system intervention. The investigators will enroll 224 older adults with hypertension to identify those who are nonadherent for one hypertension medication. The participants will be randomized to one of two groups (112 per group) to use the blood pressure system for 6-months. Both groups receive information about high blood pressure and medications. One group will also receive strategies that can be used to take medications and manage blood pressure. Both groups will complete a mid-assessment at 3-months and a post-assessment at 6-months.
Medication Adherence (MEMS Cap)
3 months, 6 months · Percentage
| Blood Pressure Technology System M | 67.29 ± 0.31 Percentage |
|---|
| Blood Pressure Technology System E | 53.72 ± 0.32 Percentage |
|---|
| Blood Pressure Technology System M | 63.47 ± 0.32 Percentage |
|---|
| Blood Pressure Technology System E | 53.56 ± 0.36 Percentage |
|---|
Medication Adherence Report Scale (MARS-5)
3 months, 6 months · Score on a scale
| Blood Pressure Technology System M | 23.62 ± 1.83 Score on a scale |
|---|
| Blood Pressure Technology System E | 24.00 ± 1.48 Score on a scale |
|---|
| Blood Pressure Technology System M | 23.94 ± 1.48 Score on a scale |
|---|
| Blood Pressure Technology System E | 23.66 ± 1.68 Score on a scale |
|---|
Открыть в BENITIONS
Открыть на ClinicalTrials.gov
Другие исследования по этому заболеванию
Все исследования
Страница обобщает открытые данные ClinicalTrials.gov. Это не медицинская и не инвестиционная рекомендация. Обратитесь к врачу.